You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
BrightSpring reported third-quarter revenue of $4.2 billion, up 26% year-over-year, and adjusted EBITDA of $228 million, up 42%. Full-year 2026 guidance calls for revenue of $15.9 to $16.125 billion and adjusted EBITDA of $850 to $860 million.
BrightSpring reported third-quarter revenue of $4.2 billion, up 26.4%, and Adjusted EBITDA of $227.8 million, up 42.0%. Net income from continuing operations increased $63.3 million to $100.8 million.
BrightSpring Health Services, Inc. reported third-quarter net revenue of $4,213 million and Adjusted EBITDA of $228 million, and raised full year 2026 Revenue guidance to $15,900 million to $16,125 million and Adjusted EBITDA guidance to $850 million to $860 million.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EPS non-GAAP | $1.37 | nine months ended September 30, 2026 | — |
|
|
|||
| Corporate Costs | -148M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| EBITDA | 531.21M | nine months ended September 30, 2026 | — |
|
|
|||
| Gross Profit per script ($) | $28.13 | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Home Health Care average daily census(3) | 46,898 | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Personal Care persons served | 16,253 | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Pharmacy Solutions Segment EBITDA non-GAAP | 551M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Prescriptions dispensed | 32,523,789 | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Provider Services Segment EBITDA non-GAAP | 220M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Rehab Care persons served(3) | 7,345 | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Revenue per script ($) | $317.03 | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Total Company Adjusted EBITDA(1) non-GAAP | 623M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Total Segment EBITDA(1) non-GAAP | 771M | Nine Months Ended September 30, 2026 | — |
| First Lien Facility paydown | $300M | second quarter of 2026 filing | — |
| Segment EBITDA non-GAAP | $74.86M | the three months ended June 30, 2026 filing | — |
| Total Segment Adjusted EBITDA non-GAAP | 255M | Three Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BTSG
this stock
BrightSpring Health Services, Inc.
|
$14.17B | +90.1% | +28.2% | 38.7 | 5.8% |
|
VEEV
Veeva Systems Inc
|
$48.82B | +35.1% | +28.1% | 49.4 | 2.4% |
|
PMDIY
Pro Medicus Ltd.
|
$14.81B | -14.6% | — | — | 0.0% |
|
TEM
Tempus AI, Inc.
|
$13.06B | +21.3% | +83.4% | — | 13.5% |
|
HNGE
Hinge Health, Inc.
|
$9.38B | +148.4% | +50.6% | 56.3 | 6.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
BrightSpring reported third-quarter revenue of $4.2 billion, up 26.4%, and Adjusted EBITDA of $227.8 million, up 42.0%. Net income from continuing operations increased $63.3 million to $100.8 million.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BTSG | +6.1% | +17.0% | +18.1% | +6.5% | +90.2% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +3.5% | +18.2% | +17.6% | +6.6% | +79.5% |
